167 related articles for article (PubMed ID: 10425663)
1. [In vitro sensitivity of Paracoccidioides brasiliensis to systemically used antifungal agents].
Rodero L; Canteros CE; Rivas C; Lee W; Davel G
Rev Argent Microbiol; 1999; 31(2):78-81. PubMed ID: 10425663
[TBL] [Abstract][Full Text] [Related]
2. In vitro susceptibilities of Paracoccidioides brasiliensis yeast form to antifungal drugs.
Hahn RC; Hamdan JS
Mycoses; 2000; 43(11-12):403-7. PubMed ID: 11204357
[TBL] [Abstract][Full Text] [Related]
3. [In vitro sensitivity tests for yeasts: evaluation of a micromethod].
Rodero LL; Davel GO; Vivot W; Canteros CE; Fernández C
Rev Argent Microbiol; 1995; 27(2):81-9. PubMed ID: 8552761
[TBL] [Abstract][Full Text] [Related]
4. [Colorimetric broth microdilution for antifungal susceptibility testing].
Yamane N; Tosaka M; Okazawa Y
Rinsho Byori; 1996 Jan; 44(1):67-75. PubMed ID: 8691643
[TBL] [Abstract][Full Text] [Related]
5. [In vitro antifungal susceptibility of dematiaceous filamentous fungi using the E-test].
Vivas JR; Torres-Rodríguez JM
Rev Esp Quimioter; 2001 Jun; 14(2):191-7. PubMed ID: 11704774
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of sequential Fonsecaea pedrosoi isolates from chromoblastomycosis patients to antifungal agents.
Andrade TS; Castro LG; Nunes RS; Gimenes VM; Cury AE
Mycoses; 2004 Jun; 47(5-6):216-21. PubMed ID: 15189187
[TBL] [Abstract][Full Text] [Related]
7. In vitro susceptibility of Cryptococcus neoformans clinical isolates from Egypt to seven antifungal drugs.
Abdel-Salam HA
Mycoses; 2005 Sep; 48(5):327-32. PubMed ID: 16115103
[TBL] [Abstract][Full Text] [Related]
8. [Determination of the in vitro antifungal susceptibility of clinically important yeasts using the Sensititre system].
Carrillo-Muñoz AJ; Quindós G; Gasser I; Tur-Tur C; Ruesga MT; Alonso-Vargas R; Arévalo P; Bornay-Llinares FJ; Santos P; del Valle O
Rev Esp Quimioter; 1999 Jun; 12(2):126-35. PubMed ID: 10562673
[TBL] [Abstract][Full Text] [Related]
9. In vitro activities of voriconazole (UK-109, 496), fluconazole, itraconazole and amphotericin B against 132 non-albicans bloodstream yeast isolates (CANARI study).
Swinne D; Watelle M; Van der Flaes M; Nolard N
Mycoses; 2004 Jun; 47(5-6):177-83. PubMed ID: 15189180
[TBL] [Abstract][Full Text] [Related]
10. [In vitro sensitivity of Histoplasma capsulatum var. capsulatum to amphotericin B, ketoconazole, itroconazole and fluconazole].
Andreu CM; León AM; Medina YE; Machín GM; Lancha MR; Zaragozí MT
Rev Cubana Med Trop; 2003; 55(2):76-82. PubMed ID: 15849960
[TBL] [Abstract][Full Text] [Related]
11. In vitro activities of five antifungal agents against pathogenic Exophiala species.
Li D; Li R; Wang D; Ma S
Chin Med J (Engl); 1999 Jun; 112(6):484-8. PubMed ID: 11601322
[TBL] [Abstract][Full Text] [Related]
12. In vitro comparison of activities of terbinafine and itraconazole against Paracoccidioides brasiliensis.
Hahn RC; Fontes CJ; Batista RD; Hamdan JS
J Clin Microbiol; 2002 Aug; 40(8):2828-31. PubMed ID: 12149337
[TBL] [Abstract][Full Text] [Related]
13. [In vitro activity of amphotericin B, fluconazole and itraconazole against Candida glabrata strains isolated from clinical samples].
Hüseyin A; Sancak B; Arikan S
Mikrobiyol Bul; 2007 Apr; 41(2):235-44. PubMed ID: 17682710
[TBL] [Abstract][Full Text] [Related]
14. [Short communication: In vitro activity of amphotericin B with fluconazole or voriconazole combinations against Candida albicans isolates].
Oz Y; Akşit F; Kiraz N; Kiremitçi A
Mikrobiyol Bul; 2008 Jan; 42(1):149-55. PubMed ID: 18444574
[TBL] [Abstract][Full Text] [Related]
15. In vitro susceptibilities of Malaysian clinical isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii to five antifungal drugs.
Tay ST; Tanty Haryanty T; Ng KP; Rohani MY; Hamimah H
Mycoses; 2006 Jul; 49(4):324-30. PubMed ID: 16784448
[TBL] [Abstract][Full Text] [Related]
16. Effects of amphotericin B and three azole derivatives on the lipids of yeast cells of Paracoccidioides brasiliensis.
Hahn RC; Hamdan JS
Antimicrob Agents Chemother; 2000 Jul; 44(7):1997-2000. PubMed ID: 10858371
[TBL] [Abstract][Full Text] [Related]
17. [Identification and antifungal susceptibility of Candida spp isolated from invasive mycoses. Influence of growth inhibition percentage to determine minimal inhibitory concentration].
Alvarado D; Díaz MC; Silva V
Rev Med Chil; 2002 Apr; 130(4):416-23. PubMed ID: 12090107
[TBL] [Abstract][Full Text] [Related]
18. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
Johnson E; Espinel-Ingroff A; Szekely A; Hockey H; Troke P
Int J Antimicrob Agents; 2008 Dec; 32(6):511-4. PubMed ID: 18790613
[TBL] [Abstract][Full Text] [Related]
19. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy.
Antoniadou A; Torres HA; Lewis RE; Thornby J; Bodey GP; Tarrand JP; Han XY; Rolston KV; Safdar A; Raad II; Kontoyiannis DP
Medicine (Baltimore); 2003 Sep; 82(5):309-21. PubMed ID: 14530780
[TBL] [Abstract][Full Text] [Related]
20. Antifungal activities of azole agents against the Malassezia species.
Miranda KC; de Araujo CR; Costa CR; Passos XS; de Fátima Lisboa Fernandes O; do Rosário Rodrigues Silva M
Int J Antimicrob Agents; 2007 Mar; 29(3):281-4. PubMed ID: 17223320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
